Recent findings highlight the neuroprotective effects associated with Nrf2-mediated induction of heme oxygenase-1 (HO-1) in diverse pathological conditions such as Alzheimer’s disease, Parkinson’s disease, and others (177–179). This evidence concerns the gene HMOX1 and early-onset autosomal dominant Alzheimer disease.